186 related articles for article (PubMed ID: 11861377)
21. Nobiletin, a citrus flavonoid, down-regulates matrix metalloproteinase-7 (matrilysin) expression in HT-29 human colorectal cancer cells.
Kawabata K; Murakami A; Ohigashi H
Biosci Biotechnol Biochem; 2005 Feb; 69(2):307-14. PubMed ID: 15725655
[TBL] [Abstract][Full Text] [Related]
22. Steps involved in activation of the pro-matrix metalloproteinase 9 (progelatinase B)-tissue inhibitor of metalloproteinases-1 complex by 4-aminophenylmercuric acetate and proteinases.
Ogata Y; Itoh Y; Nagase H
J Biol Chem; 1995 Aug; 270(31):18506-11. PubMed ID: 7629179
[TBL] [Abstract][Full Text] [Related]
23. Aspirin inhibits tumor cell invasiveness induced by Epstein-Barr virus latent membrane protein 1 through suppression of matrix metalloproteinase-9 expression.
Murono S; Yoshizaki T; Sato H; Takeshita H; Furukawa M; Pagano JS
Cancer Res; 2000 May; 60(9):2555-61. PubMed ID: 10811139
[TBL] [Abstract][Full Text] [Related]
24. Kalopanaxsaponin A inhibits PMA-induced invasion by reducing matrix metalloproteinase-9 via PI3K/Akt- and PKCdelta-mediated signaling in MCF-7 human breast cancer cells.
Park SK; Hwang YS; Park KK; Park HJ; Seo JY; Chung WY
Carcinogenesis; 2009 Jul; 30(7):1225-33. PubMed ID: 19420016
[TBL] [Abstract][Full Text] [Related]
25. EGF-induced trophoblast secretion of MMP-9 and TIMP-1 involves activation of both PI3K and MAPK signalling pathways.
Qiu Q; Yang M; Tsang BK; Gruslin A
Reproduction; 2004 Sep; 128(3):355-63. PubMed ID: 15333786
[TBL] [Abstract][Full Text] [Related]
26. Erythropoietin induction of tissue inhibitors of metalloproteinase-1 expression and secretion is mediated by mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways.
Kadri Z; Petitfrère E; Boudot C; Freyssinier JM; Fichelson S; Mayeux P; Emonard H; Hornebeck W; Haye B; Billat C
Cell Growth Differ; 2000 Nov; 11(11):573-80. PubMed ID: 11095246
[TBL] [Abstract][Full Text] [Related]
27. Functional analysis of matrix metalloproteinases and tissue inhibitors of metalloproteinases differentially expressed by variants of human HT-1080 fibrosarcoma exhibiting high and low levels of intravasation and metastasis.
Partridge JJ; Madsen MA; Ardi VC; Papagiannakopoulos T; Kupriyanova TA; Quigley JP; Deryugina EI
J Biol Chem; 2007 Dec; 282(49):35964-77. PubMed ID: 17895241
[TBL] [Abstract][Full Text] [Related]
28. Mechanisms of irregular bleeding with hormone therapy: the role of matrix metalloproteinases and their tissue inhibitors.
Hickey M; Crewe J; Mahoney LA; Doherty DA; Fraser IS; Salamonsen LA
J Clin Endocrinol Metab; 2006 Aug; 91(8):3189-98. PubMed ID: 16684831
[TBL] [Abstract][Full Text] [Related]
29. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas.
Nakano A; Tani E; Miyazaki K; Yamamoto Y; Furuyama J
J Neurosurg; 1995 Aug; 83(2):298-307. PubMed ID: 7616276
[TBL] [Abstract][Full Text] [Related]
30. Effects of genistein on invasion and matrix metalloproteinase activities of HT1080 human fibrosarcoma cells.
Yan C; Han R
Chin Med Sci J; 1999 Sep; 14(3):129-33. PubMed ID: 12903810
[TBL] [Abstract][Full Text] [Related]
31. Sp1 is an essential transcription factor for LPS-induced tissue factor expression in THP-1 monocytic cells, and nobiletin represses the expression through inhibition of NF-kappaB, AP-1, and Sp1 activation.
Hirata Y; Masuda Y; Kakutani H; Higuchi T; Takada K; Ito A; Nakagawa Y; Ishii H
Biochem Pharmacol; 2008 Apr; 75(7):1504-14. PubMed ID: 18261712
[TBL] [Abstract][Full Text] [Related]
32. Production of matrix metalloproteinases in human cultured mast cells: involvement of protein kinase C-mitogen activated protein kinase kinase-extracellular signal-regulated kinase pathway.
Kimata M; Ishizaki M; Tanaka H; Nagai H; Inagaki N
Allergol Int; 2006 Mar; 55(1):67-76. PubMed ID: 17075289
[TBL] [Abstract][Full Text] [Related]
33. Suppression of PMA-induced tumor cell invasion by capillarisin via the inhibition of NF-kappaB-dependent MMP-9 expression.
Lee SO; Jeong YJ; Kim M; Kim CH; Lee IS
Biochem Biophys Res Commun; 2008 Feb; 366(4):1019-24. PubMed ID: 18088599
[TBL] [Abstract][Full Text] [Related]
34. 1-furan-2-yl-3-pyridin-2-yl-propenone inhibits the invasion and migration of HT1080 human fibrosarcoma cells through the inhibition of proMMP-2 activation and down regulation of MMP-9 and MT1-MMP.
Park BC; Thapa D; Lee YS; Kwak MK; Lee ES; Choi HG; Yong CS; Kim JA
Eur J Pharmacol; 2007 Jul; 567(3):193-7. PubMed ID: 17507007
[TBL] [Abstract][Full Text] [Related]
35. Purification and characterization of matrix metalloproteinase 9 from U937 monocytic leukaemia and HT1080 fibrosarcoma cells.
Morodomi T; Ogata Y; Sasaguri Y; Morimatsu M; Nagase H
Biochem J; 1992 Jul; 285 ( Pt 2)(Pt 2):603-11. PubMed ID: 1379048
[TBL] [Abstract][Full Text] [Related]
36. Rhein suppresses matrix metalloproteinase production by regulating the Rac1/ROS/MAPK/AP-1 pathway in human ovarian carcinoma cells.
Zhou G; Peng F; Zhong Y; Chen Y; Tang M; Li D
Int J Oncol; 2017 Mar; 50(3):933-941. PubMed ID: 28098862
[TBL] [Abstract][Full Text] [Related]
37. Inhibitory effect of emodin on tumor invasion through suppression of activator protein-1 and nuclear factor-kappaB.
Huang Q; Shen HM; Ong CN
Biochem Pharmacol; 2004 Jul; 68(2):361-71. PubMed ID: 15194008
[TBL] [Abstract][Full Text] [Related]
38. Roles of membrane type 1 matrix metalloproteinase and tissue inhibitor of metalloproteinases 2 in invasion and dissemination of human malignant glioma.
Nakada M; Kita D; Futami K; Yamashita J; Fujimoto N; Sato H; Okada Y
J Neurosurg; 2001 Mar; 94(3):464-73. PubMed ID: 11235952
[TBL] [Abstract][Full Text] [Related]
39. Gonadotropins activate proteolysis and increase invasion through protein kinase A and phosphatidylinositol 3-kinase pathways in human epithelial ovarian cancer cells.
Choi JH; Choi KC; Auersperg N; Leung PC
Cancer Res; 2006 Apr; 66(7):3912-20. PubMed ID: 16585220
[TBL] [Abstract][Full Text] [Related]
40. Inhibitory effect of DA-125, a new anthracyclin analog antitumor agent, on the invasion of human fibrosarcoma cells by down-regulating the matrix metalloproteinases.
Park HJ; Chung HJ; Min HY; Park EJ; Hong JY; Kim WB; Kim SH; Lee SK
Biochem Pharmacol; 2005 Dec; 71(1-2):21-31. PubMed ID: 16271263
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
